Signaling Pathways - PRMT - IRAK - Adenosine A2B Receptors - HCV Proteases
清除全部
- B6182 GSK591Target: PRMTSummary: PRMT5抑制剂
- B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂
- A5618 Daclatasvir (BMS-790052)中文名: 达卡他韦Target: HCV ProteasesSummary: HCV NS5A抑制剂
- A3820 Simeprevir1 Citation中文名: 西咪匹韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂
- A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4抑制剂
- A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4抑制剂
- A3503 IRAK inhibitor 4Target: IRAKSummary: IRAK抑制剂
- A3502 IRAK inhibitor 3Target: IRAKSummary: IRAK抑制剂
- A3500 IRAK inhibitor 12 CitationTarget: IRAKSummary: IRAK-4抑制剂
- A4024 Danoprevir (RG7227)中文名: 丹诺瑞韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂